ClinVar Miner

Submissions for variant NM_000487.6(ARSA):c.211_212del (p.Cys71fs)

dbSNP: rs1057516288
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000410209 SCV000485417 likely pathogenic Metachromatic leukodystrophy 2015-12-08 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000410209 SCV001360432 likely pathogenic Metachromatic leukodystrophy 2019-08-29 criteria provided, single submitter clinical testing Variant summary: ARSA c.211_212delTG (p.Cys71HisfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.304delC, p.Leu102fsX6; c.960G>A, p.Trp320X). The variant was absent in 168270 control chromosomes (gnomAD). The variant, c.211_212delTG, has been reported in the literature in one homozygous individual affected with Metachromatic Leukodystrophy (Eng_2003). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submission from other clinical diagnostic laboratories (evaluation after 2014) cited the variant once as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Invitae RCV000410209 SCV001589206 pathogenic Metachromatic leukodystrophy 2022-12-15 criteria provided, single submitter clinical testing This premature translational stop signal has been observed in individual(s) with metachromatic leukodystrophy (PMID: 14517960). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys71Hisfs*4) in the ARSA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). This variant is also known as c.205_206delTG (p.Cys69fs). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370171).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.